U Fischer, R Vosshenrich, L Kopka, O Kahlen, E Grabbe
{"title":"[乳腺诊断和治疗干预后造影剂辅助动态磁共振乳房x线摄影]。","authors":"U Fischer, R Vosshenrich, L Kopka, O Kahlen, E Grabbe","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>In a retrospective study, the authors evaluated the signal behavior of 150 patients after intervention in the breast (40 fine-needle biopsies, 10 core biopsies, 50 open biopsies, 50 tumor-ectomies with additional irradiation therapy). The MR imaging was performed on 1.5-Tesla whole-body scanners using T1-WI GRE sequences in 2D FLASH technique before and 5 times after i.v. application of 0.1 mmol gadopentetate-dimeglumine per kg body weight. There was no signal enhancement after fine-needle biopsy. Hematoma due to core biopsy caused signal increase in every 5th patient. Enhancement after open biopsy was no more visible 6 months postoperatively. 12 months after tumorectomy and radiation therapy, most patients showed no more signal enhancement. In conclusion, MR mammography can be performed after fine-needle biopsy without problems. In case of core biopsy, hematoma should be excluded by sonography before. MR mammography should not be performed within 6 months after open biopsy, or within 12 months after tumorectomy and radiation therapy.</p>","PeriodicalId":77035,"journal":{"name":"Bildgebung = Imaging","volume":"63 2","pages":"94-100"},"PeriodicalIF":0.0000,"publicationDate":"1996-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Contrast medium assisted dynamic MR-mammography after diagnostic and therapeutic interventions on the breast].\",\"authors\":\"U Fischer, R Vosshenrich, L Kopka, O Kahlen, E Grabbe\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>In a retrospective study, the authors evaluated the signal behavior of 150 patients after intervention in the breast (40 fine-needle biopsies, 10 core biopsies, 50 open biopsies, 50 tumor-ectomies with additional irradiation therapy). The MR imaging was performed on 1.5-Tesla whole-body scanners using T1-WI GRE sequences in 2D FLASH technique before and 5 times after i.v. application of 0.1 mmol gadopentetate-dimeglumine per kg body weight. There was no signal enhancement after fine-needle biopsy. Hematoma due to core biopsy caused signal increase in every 5th patient. Enhancement after open biopsy was no more visible 6 months postoperatively. 12 months after tumorectomy and radiation therapy, most patients showed no more signal enhancement. In conclusion, MR mammography can be performed after fine-needle biopsy without problems. In case of core biopsy, hematoma should be excluded by sonography before. MR mammography should not be performed within 6 months after open biopsy, or within 12 months after tumorectomy and radiation therapy.</p>\",\"PeriodicalId\":77035,\"journal\":{\"name\":\"Bildgebung = Imaging\",\"volume\":\"63 2\",\"pages\":\"94-100\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1996-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Bildgebung = Imaging\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bildgebung = Imaging","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
在一项回顾性研究中,作者评估了150名患者在乳房干预后的信号行为(40名细针活检,10名核心活检,50名开放式活检,50名肿瘤切除术和额外的放射治疗)。在1.5-Tesla全身扫描仪上,采用t2 - wi GRE序列,2D FLASH技术,在每kg体重静脉注射0.1 mmol gadopentetate-dimeglumine之前和之后5次进行MR成像。细针活检后未见信号增强。每5例患者中有1例因核心活检导致血肿导致信号增高。术后6个月开放性活检后增强不再明显。在肿瘤切除和放疗后12个月,大多数患者的信号不再增强。总之,在细针活检后进行MR乳房x线摄影是没有问题的。在核心活检病例中,超声检查前应排除血肿。磁共振乳房x线摄影不应在开放活检后6个月内进行,或在肿瘤切除和放疗后12个月内进行。
[Contrast medium assisted dynamic MR-mammography after diagnostic and therapeutic interventions on the breast].
In a retrospective study, the authors evaluated the signal behavior of 150 patients after intervention in the breast (40 fine-needle biopsies, 10 core biopsies, 50 open biopsies, 50 tumor-ectomies with additional irradiation therapy). The MR imaging was performed on 1.5-Tesla whole-body scanners using T1-WI GRE sequences in 2D FLASH technique before and 5 times after i.v. application of 0.1 mmol gadopentetate-dimeglumine per kg body weight. There was no signal enhancement after fine-needle biopsy. Hematoma due to core biopsy caused signal increase in every 5th patient. Enhancement after open biopsy was no more visible 6 months postoperatively. 12 months after tumorectomy and radiation therapy, most patients showed no more signal enhancement. In conclusion, MR mammography can be performed after fine-needle biopsy without problems. In case of core biopsy, hematoma should be excluded by sonography before. MR mammography should not be performed within 6 months after open biopsy, or within 12 months after tumorectomy and radiation therapy.